The Role of Transglutaminase 2 (TG2) in Definition of Cancer Hallmarks

References (78)

1. 1 The Hallmarks of Cancer [DOI]
2. 2 Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis [DOI]
3. 3 The Clonal Evolution of Tumor Cell Populations [DOI]
4. 4 The retinoblastoma protein and cell cycle control [DOI]
5. 5 Transglutaminases: crosslinking enzymes with pleiotropic functions [DOI]
6. 6 Intrinsic tumour suppression [DOI]
7. 7 Transglutaminases: Nature’s biological glues [DOI]
8. 8 Cellular mechanisms of tumour suppression by the retinoblastoma gene [DOI]
9. 9 G h : a GTP-Binding Protein with Transglutaminase Activity and Receptor Signaling Function [DOI]
10. 10 Tissue Transglutaminase Is an Integrin-Binding Adhesion Coreceptor for Fibronectin [DOI]
11. 11 The ins and outs of fibronectin matrix assembly [DOI]
12. 12 Cyclins and cdks in development and cancer: a perspective [DOI]
13. 13 Protein Crosslinking in Assembly and Remodelling of Extracellular Matrices: The Role of Transglutaminases [DOI]
14. 14 Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy [DOI]
15. 15 Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer [DOI]
16. 16 Matrix-dependent Proteolysis of Surface Transglutaminase by Membrane-type Metalloproteinase Regulates Cancer Cell Adhesion and Locomotion [DOI]
17. 17 Mortality and immortality at the cellular level. A review.
18. 18 Distinct Nuclear Localization and Activity of Tissue Transglutaminase [DOI]
19. 19 A Novel RGD-independent Cell Adhesion Pathway Mediated by Fibronectin-bound Tissue Transglutaminase Rescues Cells from Anoikis [DOI]
20. 20 Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth [DOI]
21. 21 The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix [DOI]
22. 22 Tissue transglutaminase (TG2) - a wound response enzyme [DOI]
23. 23 Intracellular Localization and Activity State of Tissue Transglutaminase Differentially Impacts Cell Death [DOI]
24. 24 Tissue Transglutaminase Protects against Apoptosis by Modifying the Tumor Suppressor Protein p110 Rb [DOI]
25. 25 High levels of transglutaminase expression in doxorubicin‐resistant human breast carcinoma cells [DOI]
26. 26 Tissue transglutaminase-mediated chemoresistance in cancer cells [DOI]
27. 27 Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer [DOI]
28. 28 Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer [DOI]
29. 29 Identification of a Novel Recognition Sequence for Fibronectin within the NH2-terminal β-Sandwich Domain of Tissue Transglutaminase [DOI]
30. 30 Complexation of fibronectin with tissue transglutaminase [DOI]
31. 31 Interaction of tissue transglutaminase with nuclear transport protein importin‐α3 [DOI]
32. 32 Tissue transglutaminase: from biological glue to cell survival cues [DOI]
33. 33 New insights into the functions and localization of nuclear transglutaminase 2 [DOI]
34. 34 Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells [DOI]
35. 35 Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence [DOI]
36. 36 Regulated Expression of Tissue Transglutaminase in Swiss 3T3 Fibroblasts: Effects on the Processing of Fibronectin, Cell Attachment, and Cell Death [DOI]
37. 37 Absence of oats toxicity in adult coeliac disease: Table 1 [DOI]
38. 38 Cell Surface Localization of Tissue Transglutaminase Is Dependent on a Fibronectin-binding Site in Its N-terminal β-Sandwich Domain [DOI]
39. 39 Interaction Site of GTP Binding Gh (Transglutaminase II) with Phospholipase C [DOI]
40. 40 Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers [DOI]
41. 41 GTP Binding and Signaling by Gh/Transglutaminase II Involves Distinct Residues in a Unique GTP-binding Pocket [DOI]
42. 42 Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei [DOI]
43. 43 Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. [DOI]
44. 44 Ligand-Induced Conformational Changes in Tissue Transglutaminase: Monte Carlo Analysis of Small-Angle Scattering Data [DOI]
45. 45 Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells [DOI]
46. 46 Tissue Transglutaminase at Embryo-Maternal Interface [DOI]
47. 47 Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility [DOI]
48. 48 Survival pathways meet their end [DOI]
49. 49 Conformational Changes in the Nucleosome Followed by the Selective Accessibility of Histone Glutamines in the Transglutaminase Reaction: Effects of Ionic Strength [DOI]
50. 50 COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective [DOI]
51. 51 Hallmarks of Cancer: The Next Generation [DOI]
52. 52 The Bcl-2 apoptotic switch in cancer development and therapy [DOI]
53. 53 New York, USA
54. 54 Fibronectin Polymerization Regulates the Composition and Stability of Extracellular Matrix Fibrils and Cell-Matrix Adhesions [DOI]
55. 55 The angiogenic switch in carcinogenesis [DOI]
56. 56 Transglutaminase 2: an enigmatic enzyme with diverse functions [DOI]
57. 57 Roles for Growth Factors in Cancer Progression [DOI]
58. 58 Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
59. 59 Oats induced villous atrophy in coeliac disease [DOI]
60. 60 Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer [DOI]
61. 61 The role of tissue transglutaminase in cell-matrix interactions [DOI]
62. 62 Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells [DOI]
63. 63 Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. [DOI]
64. 64 Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin [DOI]
65. 65 Increased Expression of Tissue Transglutaminase in Pancreatic Ductal Adenocarcinoma and Its Implications in Drug Resistance and Metastasis [DOI]
66. 66 Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme [DOI]
67. 67 Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase [DOI]
68. 68 Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells [DOI]
69. 69 Implications of tissue transglutaminase expression in malignant melanoma [DOI]
70. 70 Identification of the Calcium Binding Site and a Novel Ytterbium Site in Blood Coagulation Factor XIII by X-ray Crystallography [DOI]
71. 71 Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer [DOI]
72. 72 Crystal Structure of Red Sea Bream Transglutaminase [DOI]
73. 73 Opposite Effects of Ca2+ and GTP Binding on Tissue Transglutaminase Tertiary Structure [DOI]
74. 74 Tissue transglutaminase mediates the pro‐malignant effects of oncostatin M receptor over‐expression in cervical squamous cell carcinoma [DOI]
75. 75 Biological Functionalities of Transglutaminase 2 and the Possibility of Its Compensation by Other Members of the Transglutaminase Family [DOI]
76. 76 Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity [DOI]
77. 77 Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor [DOI]
78. 78 Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools [DOI]

Cited by 0

No indexed citations yet.

Related research

• Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
• Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
• Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
• Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
• Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage